Home » Stocks » Cardax

Cardax Inc. (CDXI)

Stock Price: $3.50 USD 0.00 (0.00%)
Updated Sep 18, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 2.66M
Revenue (ttm) 777,920
Net Income (ttm) -5.58M
Shares Out 758,904
EPS (ttm) -7.91
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Sep 18, 2020
Last Price $3.50
Previous Close $3.50
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 3.50 - 3.60
Day's Volume 0
52-Week Range 2.00 - 15.00

More Stats

Market Cap 2.66M
Enterprise Value 6.55M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 758,904
Float 575,200
EPS (basic) -7.18
EPS (diluted) -7.91
FCF / Share -3.26
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.92
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 3.41
PB Ratio n/a
Revenue 777,920
Operating Income -3.61M
Net Income -5.58M
Free Cash Flow -2.46M
Net Cash -3.90M
Net Cash / Share -5.14
Gross Margin 46.99%
Operating Margin -463.86%
Profit Margin -717.20%
FCF Margin -315.90%
ROA -118.71%
ROE n/a
ROIC 94.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$200.00*
Low
200
Current: $3.50
High
200
Target: 200.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue0.711.510.610.04---0.01
Revenue Growth-52.94%147.55%1631.02%-----
Gross Profit0.370.810.340.02---0.01
Operating Income-4.08-4.02-2.00-1.83-4.40-16.88-3.61-1.80
Net Income-5.09-4.02-1.99-1.78-4.26-16.99-4.36-2.54
Shares Outstanding0.680.640.500.380.330.300.170.05
Earnings Per Share-7.49-6.32-4.00-4.00-12.00-56.00-26.00-54.00
Operating Cash Flow-3.52-3.20-2.08-1.26-1.51-5.70-4.13-1.16
Capital Expenditures----0.010.09-0.03-
Free Cash Flow-3.52-3.20-2.08-1.26-1.50-5.61-4.16-1.16
Cash & Equivalents0.020.242.240.160.320.040.220.01
Total Debt2.59-----9.044.11
Net Cash / Debt-2.570.242.240.160.320.04-8.82-4.10
Assets2.022.463.160.750.851.551.771.48
Liabilities9.225.994.564.644.604.7614.7010.07
Book Value-7.20-3.54-1.41-3.89-3.75-3.21-12.94-8.58
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cardax Inc.
Country United States
Employees 11
CEO David G. Watumull

Stock Information

Ticker Symbol CDXI
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: CDXI

Description

Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an anti-inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate; and CDX-301, a zeaxanthin pharmaceutical candidate for pharmaceutical applications. The company has a joint development and supply agreement with BASF SE, as well as a collaboration agreement with Capsugel US, LLC for the development of astaxanthin products for the consumer health market. Cardax, Inc. is based in Honolulu, Hawaii.